Three more arrested for attack on Bajrang Dal activist

Mangaluru, May 13: Coastal district of Dakshina Kannada today reported a fresh covid-19 positive case. According to sources, this case also linked to Manglauru’s First Neuro Hospital, which has emerged as the corona hub of coastal Karnataka.

Health and Family Welfare department in its today’s bulletin revealed that a 38-year-old woman from Darandabagilu near Someshwara in Mangaluru taluk of Dakshina Kannada was tested coronavirus positive.

It is said that the woman was in touch with P-507, an octogenarian, who was being treated for neurological issues at First Neuro Hospital.

With this the total number of coronavirus positive cases reported in Dakshina Kannada rose to 34. Among them only 26 are residents of Dakshina Kannada. Four are from Kasaragod, three from Udupi and one from Bhatkal.

Among 34, currently there only 17 active cases. The condition of two among them is said to be critical.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Mangaluru/ Udupi, June 19: As many as 13 fresh coronavirus positive cases were reported in Dakshina Kannada on June 19, taking the total number of cases in the coastal district to 414. In Udupi, the total number of covid cases mounted to 1,050 with 11 new cases.

Four among the 13 patients in Dakshina Kannada had returned from Saudi Arabia and seven had returned from Sharjah recently. Two others were suffering from an influenza-like illness (ILI). All the 13 patients have been shifted to the designated COVID hospital in Mangaluru.

In Udupi, three among the 11 new covid patients are children. Four are Maharashtra returnees and two had come from Tamil Nadu. Five others have contracted infection from other positive patients. 

Only 98 cases are currently active in Udupi among 1,050. As many as 950 patients have been discharged from hospital. Two deaths have occurred in the district including one on Friday.